Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.61 per Share
May 24, 2024 09:00 ET
|
Northrim BanCorp Inc
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.61 per Share
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024 08:45 ET
|
FN Media Group LLC
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the...
Safe & Green Holdings Receives Crucial International Code Council (ICC), Recertification for Use of Shipping Containers in Modular Construction
May 24, 2024 08:30 ET
|
Safe & Green Holdings Corp.
Shipping container used in modular construction MIAMI, FL, May 24, 2024 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a...
Golden Triangle Ventures Announces Letter of Intent to Acquire Shipping and Logistics Operation
May 24, 2024 08:30 ET
|
Golden Triangle Ventures, Inc.
LAS VEGAS, May 24, 2024 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is pleased to announce the execution of a Letter of Intent (or “LOI”)...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGR, OSG, SSB
May 24, 2024 08:18 ET
|
Halper Sadeh LLC
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 24, 2024 08:01 ET
|
Perspective Therapeutics, Inc.
SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment...
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
May 24, 2024 08:00 ET
|
Genelux Corporation
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Monopar Announces CFO Succession
May 24, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer...
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 24, 2024 08:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting
May 24, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab